Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytes

PLoS Pathogens(2021)10.1371/journal.ppat.1009834Source: DataRank Database

EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytes is a research paper published in PLoS Pathogens (2021). On theSindex it has a DataRank of 0. It has been cited 20 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access20 citations

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (18 grants)Impact (FWCI 1.05)OA: goldTopics (51)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Fang Lü ORCID,Samantha S. Soldan ORCID,Jason Lamontagne ORCID,Hsin‐Yao Tang ORCID,Giorgia Napoletani ORCID

Live enrichment

PubMed:34352044 PMC:PMC8370649 OpenAlex:https://openalex.org/W3188651380

National Cancer Institute

Grant: R01 CA093606

National Institute of Dental and Craniofacial Research

Grant: R01 DE017336

National Institute of Allergy and Infectious Diseases

Grant: R01 AI153508

National Institute of Allergy and Infectious Diseases

Grant: R01AI130209

National Institutes of Health

Grant: R50 CA221838

National Institutes of Health

Grant: R50 CA211199

national institutes of health

Grant: P30 CA010815

Medical Research Council

Grant: S0022597/1

NIHR Imperial Biomedical Research Centre

Grant: BRC

Medical Research Council

Grant: MR/S022597/1

Medical Research Council

Grant: MR/S0022597/1

National Institutes of Health

Grant: 5R01AI153508-03

Regulation of EBV Latency by Purine Metabolism and Signaling

National Institutes of Health

Grant: 5R01CA093606-13

Regulation of EBV Latency by EBNA1

National Institutes of Health

Grant: 5P30CA010815-28

CONSOLIDATED BASIC CANCER RESEARCH PROGRAM

National Institutes of Health

Grant: 2R50CA221838-06

Advancing Cancer Research through Comprehensive Proteomics and Metabolomics Analyses

National Institutes of Health

Grant: 5R01DE017336-12

Epigenetic Regulation of Epstein-Barr Virus

National Institutes of Health

Grant: 7R01AI130209-04

Regulation of Viral Chromatin Architecture During EBV Latency

National Institutes of Health

Grant: 5R50CA211199-04

Integrative Approach to Comprehensive Analysis of High Throughput Data on a Cancer Center Level

FWCI

1.05

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1009834&type=printable

publisherhttps://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1009834&type=printable

publisherhttps://dx.plos.org/10.1371/journal.ppat.1009834

journalhttps://doi.org/10.1371/journal.ppat.1009834

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34352044

Fields of Study

Viral-associated cancers and disordersImmune Cell Function and InteractionLymphoma Diagnosis and Treatment0301 basic medicine03 medical and health sciences

MeSH Terms

B-LymphocytesDNA-Binding ProteinsEnhancer Elements, GeneticHerpesvirus 4, HumanGene Expression RegulationGenes, MHC Class IIHumansMembrane ProteinsNuclear ProteinsPromoter Regions, GeneticViral ProteinsTrans-ActivatorsEpstein-Barr Virus Nuclear AntigensEpstein-Barr Virus Infections

Keywords

CIITAEnhancerBiologyTranscription (linguistics)GeneTranscriptional regulationGeneticsTranscription factorCell biologyMHC class IIMajor histocompatibility complexB-LymphocytesEpstein-Barr Virus InfectionsHerpesvirus 4, HumanQH301-705.5Genes, MHC Class II500Membrane ProteinsNuclear ProteinsRC581-607DNA-Binding ProteinsViral ProteinsEnhancer Elements, GeneticEpstein-Barr Virus Nuclear AntigensGene Expression Regulation616Trans-ActivatorsHumansImmunologic diseases. AllergyBiology (General)Promoter Regions, GeneticResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytes

FAIR Checklist

Authors (10)

Funding (18 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)